AML , Myelodysplasia‐Related With B/Myeloid MPAL Immunophenotype, Normal Karyotype, and SRSF2 / ASXL1 / FLT3 Co‐Mutations
International Journal of Laboratory Hematology · 2026-08 · 48 (4) · 708-709
DOI: 10.1111/ijlh.70092 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 18.03.2026. Verfasst von Zhaodong Xu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Division of Hematopathology, Vancouver General Hospital. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Division of Hematopathology, Vancouver General Hospital.
ORCID-Profile: Zhaodong Xu, Monika Hudoba
Zitieren
APA
Xu, Z., & Hudoba, M. (2026). AML , Myelodysplasia‐Related With B/Myeloid MPAL Immunophenotype, Normal Karyotype, and SRSF2 / ASXL1 / FLT3 Co‐Mutations. International Journal of Laboratory Hematology, 48(4), 708-709. https://doi.org/10.1111/ijlh.70092
Vancouver
Xu Z, Hudoba M. AML , Myelodysplasia‐Related With B/Myeloid MPAL Immunophenotype, Normal Karyotype, and SRSF2 / ASXL1 / FLT3 Co‐Mutations. International Journal of Laboratory Hematology. 2026;48(4):708-709. doi:10.1111/ijlh.70092
BibTeX
@article{Xu2026,
author = {Xu, Zhaodong and Hudoba, Monika},
title = {AML , Myelodysplasia‐Related With B/Myeloid MPAL Immunophenotype, Normal Karyotype, and SRSF2 / ASXL1 / FLT3 Co‐Mutations},
journal = {International Journal of Laboratory Hematology},
year = {2026},
volume = {48},
number = {4},
pages = {708--709},
doi = {10.1111/ijlh.70092}
}
EUVIMED